| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/30/2008 | US7429468 thermostable mutants of B-type DNA polymerases comprising a Y-GG/A amino acid motif between the N-terminal 3'-5'-exonuclease domain and the C-terminal polymerase domain whereas the tyrosine of the Y-GG/A amino acid motif is mutated and whereas these mutant DNA polymerases are suitable for PCR. |
| 09/30/2008 | US7429467 Solution comprising surfactant, hydrophobic phase and hydrophilic phase comprising plurality of microcapsules containing functional in vitro eukaryotic expression system for transfer of heterologous into cells |
| 09/30/2008 | US7429459 for identifying compounds that inhibit amyloidal-beta precursor protein processing in cells, comprising contacting a test compound with a GPCR polypeptide, or fragment thereof, and measuring a compound-GPCR property related to the production of amyloidal-beta peptide. |
| 09/30/2008 | US7429450 HIP1 cancer markers |
| 09/30/2008 | US7429385 Isolated, genetic engineered polypeptide |
| 09/30/2008 | US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 09/30/2008 | US7429380 Production of a multimeric protein by cell fusion method |
| 09/30/2008 | US7429379 TNF receptor action modulation |
| 09/30/2008 | CA2295604C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 09/30/2008 | CA2264953C Modifying insect cell gylcosylation pathways with baculovirus expression vectors |
| 09/30/2008 | CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 09/30/2008 | CA1341581C Leukaemia inhibitory factor |
| 09/30/2008 | CA1341580C Tissue-type plasminogen activator mutants |
| 09/25/2008 | WO2008115887A2 Labeled biomolecular compositions and methods for the production and uses thereof |
| 09/25/2008 | WO2008115596A2 Over expression of foldases and chaperones improves protein production |
| 09/25/2008 | WO2008115428A2 A scaleable manufacturing process for cysteine endoprotease b, isoform 2 |
| 09/25/2008 | WO2008115404A1 Treatment method using egfr antibodies and src inhibitors and related formulations |
| 09/25/2008 | WO2008114733A1 Anti-claudin-4 antibody |
| 09/25/2008 | WO2008114709A1 Biomarker specific to blood cell or specific to osteoclast differentiation |
| 09/25/2008 | WO2008114673A1 Method for production of polypeptide |
| 09/25/2008 | WO2008114672A1 Cancer-specific biomarker |
| 09/25/2008 | WO2008114501A1 Diagnostic agent and therapeutic agent for cancer |
| 09/25/2008 | WO2008114488A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114487A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008113799A1 Novel lysyl oxidases |
| 09/25/2008 | WO2008048519A3 Antibodies that bind cxcr7 epitopes |
| 09/25/2008 | WO2008034119A3 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 09/25/2008 | WO2007117410A3 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies |
| 09/25/2008 | WO2007087420A8 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 09/25/2008 | WO2007081534A3 Method of producing catalytically active bace2 enzymes |
| 09/25/2008 | US20080235822 Nucleic acids encoding chimeric polypeptides allowing expression of plant-noxious proteins |
| 09/25/2008 | US20080235815 Generating transgenic avians via transformation of urogenital systems for use in expression of heterologous genes; bioreactors |
| 09/25/2008 | US20080235814 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
| 09/25/2008 | US20080235813 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 09/25/2008 | US20080234471 Dna sequence; open-reading frame; genetic engineering |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234469 Binding to monoclonal antibodies; antitumor agents |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234187 In particular amidated, acetylated, phosphorylated and/or glycosylated derivatives; diagnostic agents including a nucleic acid or messenger RNA coding for the cytokine; isolated from human hemofiltrate |
| 09/25/2008 | US20080234184 These membrane domains are of viral envelope proteins that allow viruses to anchor to the target cells that they will infect; allows coexpression of the TME1 and TME2 membrane domains of the hepatitis C virus envelope proteins |
| 09/25/2008 | US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 09/25/2008 | US20080233646 Human DR4 antibodies and uses thereof |
| 09/25/2008 | US20080233639 Fusion protein delivery system and uses thereof |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233615 stress-related fusion proteins, antigenic peptides, and anti-stress-related antibodies; nucleic acid molecule encodes polypeptide which increases bile tolerance of cell; Lactobacillus acidophilus cell with an increased ability to survive stressful conditions compared to a wild-type |
| 09/25/2008 | US20080233614 codon-optimized genes designed to help maximize expression level; making collegenase |
| 09/25/2008 | US20080233613 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 09/25/2008 | US20080233612 Fungal Hosts for Expression of Recombinant Products |
| 09/25/2008 | US20080233611 pairs of orthogonal-tRNAs (O-tRNAs) and orthogonal aminoacyl-tRNA synthetases (O RSs) that do not interact with the host cell translation machinery |
| 09/25/2008 | US20080233608 Genes and proteins involved in lipid remodeling of gpi-anchored proteins and the use thereof |
| 09/25/2008 | US20080233560 DNA-transfection system for the generation of infectious influenza virus |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233138 Coccidiosis Poultry Vaccine |
| 09/25/2008 | US20080233123 Polypeptide from haemophilus influenzae |
| 09/25/2008 | US20080233122 Complementarity determining regions; immunoglobulins; cell line, host cells; transgenic animals, plants |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233116 Human monoclonal antibodies to CTLA-4 |
| 09/25/2008 | US20080233110 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2008 | US20080233109 Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof |
| 09/25/2008 | US20080233086 Expression Vectors for Treating Bacterial Infections |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | US20080230399 Fructosylamine Oxidase |
| 09/25/2008 | CA2681035A1 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 09/24/2008 | EP1972194A1 Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 09/24/2008 | EP1751299A4 Methods for evaluating ribonucleotide sequences |
| 09/24/2008 | EP1368476B1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/24/2008 | EP1029046B1 Wnt-1 inducible genes |
| 09/24/2008 | CN101273141A Targeted integration and expression of exogenous nucleic acid sequences |
| 09/24/2008 | CN101273140A Compositions of tRNA and uses thereof |
| 09/24/2008 | CN101273129A Recombinant vector capable of increasing secretion of koji mold protease |
| 09/24/2008 | CN101272693A Process for production of fermented milk and fermented milk beverage/food |
| 09/24/2008 | CN101270380A Screening method for hybrid tumor cell monoclonal preparation |
| 09/24/2008 | CN101270379A Preparation method for abstracting collagen helical peptide from wood frog tissue |
| 09/24/2008 | CN101270344A Bacillus subtillis for preventing and controlling cole sclerotium and antibioticsubstance separation |
| 09/24/2008 | CN101270150A Truncate soluble human vascellum endothelial cell growth factor acceptor, prepraring method and uses thereof |
| 09/24/2008 | CN101269090A Method of preparing low molecular weight colla carapaeis corii asini hydrolysate |
| 09/24/2008 | CN100420750C Chinese prawn C-type agglutinin gene and its coded C-type agglutinin peptide and uses |
| 09/24/2008 | CN100420746C Design and fermented production of recombinant peptide for reducing blood pressure |
| 09/23/2008 | US7427671 DNA sequence which code human platelet derived growth factor receptor proteins which preferentially binds to dimers of platelet derived growth factors with high receptivity |
| 09/23/2008 | US7427670 Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof |
| 09/23/2008 | US7427669 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 09/23/2008 | US7427668 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 09/23/2008 | US7427667 monoclonal; humanized; fragments; labeled |
| 09/23/2008 | US7427666 Antibody directed against a ubiquitin-specific protease occurring in the brain |
| 09/23/2008 | US7427664 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 09/23/2008 | US7427660 Tumor antigen |
| 09/23/2008 | US7427659 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
| 09/23/2008 | US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 09/23/2008 | US7427602 nucleic acid-matrix materials are created such that they maintain a defined space, allowing cellular migration, transfection and proliferation to occur in a controlled manner; in vivo cell transfection and gene expression |
| 09/23/2008 | US7427592 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 09/23/2008 | US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427494 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
| 09/23/2008 | US7427493 Recombinant genes for polyketide modifying enzymes |
| 09/23/2008 | US7427487 for the direct identification of candidate compounds such as receptor agonists, inverse agonists, partial agonist or antagonist for use in graft rejection; inflammatory skin disease; inflammatory bowel disease; allergic inflammation, pulmonary inflammation, inflammatory demyelinating neuropathy |
| 09/23/2008 | US7427471 Modified “S” antibodies |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |